MDAI vs CBLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 31, 2026

MDAI

47.0
AI Score
VS
MDAI Wins

CBLL

45.3
AI Score

Investment Advisor Scores

MDAI

47score
Recommendation
HOLD

CBLL

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDAI CBLL Winner
Revenue 3.99M 26.49M CBLL
Net Income -3.41M -19.74M MDAI
Gross Margin 50.8% 87.3% CBLL
Net Margin -85.5% -74.5% CBLL
Operating Income -1.97M -20.75M MDAI
ROE 38.7% -14.0% MDAI
ROA -19.2% -11.1% CBLL
Total Assets 17.73M 178.08M CBLL
Cash 11.70M 45.25M CBLL
Current Ratio 0.75 10.44 CBLL

Relative Price Performance (Last 90 Days)

MDAI 1M: -10.1% · 3M: -25.1% CBLL 1M: -6.3% · 3M: -10.7%

Current Technical Phase

MDAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 43

RSI (14): 43.4 · Price: $1.61

CBLL

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.8%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $18.31

Fundamentals Snapshot

Metric MDAI CBLL
Market Cap
Forward P/E -4.5 -16.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% 0.3%
Gross Margin 0.5% 0.9%
Operating Margin -0.5% -0.8%
EPS -0.53 -1.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDAI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.